Aneuploidies
- Absent nasal bone in the first trimester: second trimester follow up
- Aneuploidy screening in women of advanced age in a limited resource public health care setting
- Artificial intelligence to detect increased nuchal translucency in the first trimester of pregnancy
- Assessment of the nasal bone at 11+0 to 13+6 weeks gestation
- Atypicality index as an add-on to combined first-trimester screening for chromosomal aberrations
- Chromosomal microarray or conventional karyotype in fetuses with increased nuchal translucency
- Enhancing prenatal risk assessment in combined first trimester screening in twins
- Extending the measurement of nuchal translucency up to 14+6 weeks
- Fetuses with increased nuchal translucency and normal karyotype
- First trimester combined test and intermediate risk for trisomies: experience of a Portuguese centre
- Increased nuchal translucency and aneuploidies
- Increased nuchal translucency and neurodevelopmental delay in fetuses with normal karyotype
- Increased nuchal translucency before 11 weeks of gestation
- New cut off of nuchal fold in structurally abnormal fetuses at 18 – 20 weeks
- Outcome of pregnancies with nuchal translucency <5th percentile
- Postnatal diagnosis of congenital cutis laxa syndrome in a fetus with increased nuchal translucency
- Prenatal detection of atypical chromosomal aberrations from FMF combined first-trimester screening
- Prognosis and neonatal outcome in fetuses with increased nuchal translucency
- Screening for trisomy 21: adjustment of biochemical markers to maternal weight
- Screening of nuchal fold thickness at 15 – 17 weeks
- Trisomy 21 screening with alpha software and FMF algorithm in South African private practice
- Trisomy 21 screening with FMF algorithm in South African private practice